Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies (Q84552985)
Jump to navigation
Jump to search
scientific article published on 01 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies |
scientific article published on 01 July 2010 |
Statements
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies (English)
Richard G Langley
Robert Bissonnette
Darryl Toth
Robert Matheson
Micki Hultquist